82 related articles for article (PubMed ID: 13313178)
1. Unsuccessful attempt to demonstrate a paralytic factor in serum of myasthenia gravis patients.
VAN DER MOST VAN SPIJK D
Acta Physiol Pharmacol Neerl; 1956 Mar; 4(4):591-4. PubMed ID: 13313178
[No Abstract] [Full Text] [Related]
2. Unsuccessful attempt to demonstrate a paralytic factor in serum of myasthenia gravis patients.
LAMMERS W; MOST VAN SPIJK D
Nature; 1954 Jun; 173(4416):1192-3. PubMed ID: 13176414
[No Abstract] [Full Text] [Related]
3. Curare-like factor in serum of myasthenia gravis patients.
SCHWARZ H
Can Med Assoc J; 1952 Sep; 67(3):238-47. PubMed ID: 13009528
[No Abstract] [Full Text] [Related]
4. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
6. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
[TBL] [Abstract][Full Text] [Related]
7. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
Chen Y; Wang W; Wei D; Yang L
Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
[TBL] [Abstract][Full Text] [Related]
8. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
[TBL] [Abstract][Full Text] [Related]
10. Effect of thymectomy on blood T-cell subsets in myasthenia gravis.
Cox A; Lisak RP; Skolnik P; Zweiman B
Ann Neurol; 1986 Mar; 19(3):297-8. PubMed ID: 3485953
[TBL] [Abstract][Full Text] [Related]
11. Seronegative myasthenia gravis associated with malignant thymoma.
Richards J; Howard JF
Neuromuscul Disord; 2017 May; 27(5):417-418. PubMed ID: 28238572
[TBL] [Abstract][Full Text] [Related]
12. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
14. Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3.
Duman O; Koken R; Baran RT; Haspolat S; Topaloglu H
Eur J Paediatr Neurol; 2014 Jul; 18(4):526-8. PubMed ID: 24685514
[TBL] [Abstract][Full Text] [Related]
15. Does increased serum IL-17 level imply its pathogenic role in myasthenia gravis?
Li HF; Xie YC
Muscle Nerve; 2012 Jan; 45(1):147; author reply 147-8. PubMed ID: 22190324
[No Abstract] [Full Text] [Related]
16. Serum BAFF expression in patients with myasthenia gravis.
Kim JY; Yang Y; Moon JS; Lee EY; So SH; Lee HS; Park KD; Choi YC
J Neuroimmunol; 2008 Aug; 199(1-2):151-4. PubMed ID: 18586330
[TBL] [Abstract][Full Text] [Related]
17. B-cell-activating factor is elevated in serum of patients with myasthenia gravis.
Kang SY; Kang CH; Lee KH
Muscle Nerve; 2016 Dec; 54(6):1030-1033. PubMed ID: 27121160
[TBL] [Abstract][Full Text] [Related]
18. Studies on the inhibitor of acetylcholine synthesis in the serum of patients with myasthenia gravis.
Nakao K; Wada F
Med J Osaka Univ; 1968 Sep; 19(1):41-8. PubMed ID: 5710969
[No Abstract] [Full Text] [Related]
19. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
20. Hemidiaphragm atrophy in muscle-specific kinase myasthenia gravis.
Cartwright MS; Keskinyan VS
Muscle Nerve; 2016 Aug; 54(2):338-9. PubMed ID: 26852898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
